Fabrication of multiwalled carbon nanotube-surfactant modified sensor for the direct determination of toxic drug 4-aminoantipyrine

4-Dimethylaminoantipyrine as a Broad Electrochemical Indicator for Immunosensors Platform

Here, we describe 4-dimethylaminoantipyrine (4-DMAA)-mediated interfacing as a broad biochemical indicator to stabilize and promote the higher response of electrodes for immunological detection. We hypothesized that the improved biological interactions of 4-DMAA with electrodes and biological samples may be due to the interaction properties of the benzene and pyrazole chemical groups with graphite and proteins, respectively. In order to demonstrate that 4-DMAA could be used as a general indicator in electrochemical immunoassays, we used peptides as probes for the diagnosis of four neglected tropical infectious diseases Tegumentary leishmaniasis, Visceral leishmaniasis, Strongyloidiasis, and Leprosy on commercial graphite screen-printed electrodes. 4-DMAA oxidation was used to indicate specific biological recognition between the epitope-based peptide and serum immunoglobulin G (IgG) from infected patients. We demonstrated that 4-DMAA should be incorporated into the electrodes prior to serum application, which avoids interference with its sensitivity and specificity. In addition, 4-DMAA oxidizes at a low anodic potential, and the oxidation peak is useful for detecting proteins in biological fluids. In summary, we have successfully demonstrated the broad application of 4-DMAA as a general indicator for the specific diagnosis of four infectious diseases in electrochemical immunosensors. Such a strategy is quite advantageous for indirect detection of proteins that lack electrochemical activities or are spatially inaccessible on the electrode surface. This new indicator opens a new avenue for monitoring biological recognition, especially for immunosensors.

Carbon Nanomaterial-Based Drug Sensing Platforms Using State-of-the- Art Electroanalytical Techniques

Background:

Currently, nanotechnology and nanomaterials are considered as the most popular and outstanding research subjects in scientific fields ranging from environmental studies to drug analysis. Carbon nanomaterials such as carbon nanotubes, graphene, carbon nanofibers etc. and non-carbon nanomaterials such as quantum dots, metal nanoparticles, nanorods etc. are widely used in electrochemical drug analysis for sensor development. Main aim of drug analysis with sensors is developing fast, easy to use and sensitive methods. Electroanalytical techniques such as voltammetry, potentiometry, amperometry etc. which measure electrical parameters such as current or potential in an electrochemical cell are considered economical, highly sensitive and versatile techniques.

Methods:

Most recent researches and studies about electrochemical analysis of drugs with carbon-based nanomaterials were analyzed. Books and review articles about this topic were reviewed.

Results:

The most significant carbon-based nanomaterials and electroanalytical techniques were explained in detail. In addition to this; recent applications of electrochemical techniques with carbon nanomaterials in drug analysis was expressed comprehensively. Recent researches about electrochemical applications of carbon-based nanomaterials in drug sensing were given in a table.

Conclusion:

Nanotechnology provides opportunities to create functional materials, devices and systems using nanomaterials with advantageous features such as high surface area, improved electrode kinetics and higher catalytic activity. Electrochemistry is widely used in drug analysis for pharmaceutical and medical purposes. Carbon nanomaterials based electrochemical sensors are one of the most preferred methods for drug analysis with high sensitivity, low cost and rapid detection.

A new CQDs/f-MWCNTs/GO nanocomposite electrode for arsenic (10−12M) quantification in bore-well water and industrial effluents

Strategic combination ofCQDs/f-MWCNTs/GO/GCE for pico-molar arsenic sensing.

Degradation of 4-aminoantipyrine by electro-oxidation with a boron-doped diamond anode: Optimization by central composite design, oxidation products and toxicity

Electro-oxidation with electrogenerated H₂O₂ (EO-H₂O₂) was applied to treat acidic aqueous solutions of 4-aminoantipyrine (4-AA), a persistent drug metabolite of dipyrone, in sulfate medium. Trials were made using a boron-doped diamond anode in the presence of H₂O₂ electrogenerated on site. A 2⁴ central composite design (CCD) was employed to evaluate the effect of four independent variables, namely current density (j), pH, 4-AA concentration and electrolysis time, on the percentages of degradation and mineralization, as well as on mineralization current efficiency (MCE). Predicted responses agreed with observed values, showing linear trendlines with good R² and R²_adj values. The degradation was optimum at j=77.5mAcm^-2, pH3.5 and 62.5mgL^-1 4-AA, leading to 63% and 99% removal after 3 and 7min, respectively. For those solutions, the largest mineralization was found at j=77.5mAcm^-2, attaining 45% abatement at 175min. Low MCE values were obtained in all electrolyses. An initial route for 4-AA degradation is proposed based on one dimer and eleven aromatic and aliphatic intermediates detected in the treated solutions at pH3.5 by LC-MS. The initial 62.5mgL^-1 solution at pH3.5 presented acute toxicity on Artemia salina larvae, with LC₅₀=13.6mgL^-1, being substantially reduced after 3 and 7min of EO-H₂O₂ at j=77.5mAcm^-2 due to the formation of less toxic derivatives.

Nanostructured materials in electroanalysis of pharmaceuticals

Basic strategies and recent developments for the enhancement of the sensory performance of nanostructures in the electroanalysis of pharmaceuticals are reviewed. A discussion of the properties of nanostructures and their application as modified electrodes for drug assays is presented. The electrocatalytic effect of nanostructured materials and their application in determining low levels of drugs in pharmaceutical forms and biofluids are discussed.